title: Discrepancy between clinical symptoms and Tc-99m MDP bone scan findings before and after strontium-89 therapy for metastatic bone pain of prostate carcinoma.
authors.affiliation: Department of Nuclear Medicine, China Medical College Hospital, Taichung, Taiwan.
authors.forename: S S
authors.initials: SS
authors.lastname: Sun
authors.forename: S C
authors.initials: SC
authors.lastname: Tsai
authors.forename: J F
authors.initials: JF
authors.lastname: Hsieh
authors.forename: J K
authors.initials: JK
authors.lastname: Lee
authors.forename: C H
authors.initials: CH
authors.lastname: Kao
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000150:complications / Q000000981:diagnostic imaging* / Q000556:secondary*; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D010148:Intractable Pain / Q000209:etiology* / Q000532:radiotherapy*; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000473:pathology*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013326:Strontium Radioisotopes / Q000627:therapeutic use; D013669:Technetium Tc 99m Medronate
chemical_list: D019275:Radiopharmaceuticals; D013326:Strontium Radioisotopes; D013669:Technetium Tc 99m Medronate